T-helper Type 2 Polarization Among Asthmatics During and Following Pregnancy

Overview

Journal Clin Exp Allergy

Specialty Allergy & Immunology

Date 2006 Jul 15

PMID 16839404

Citations 7

Authors

D Rastogi

C Wang

C Lendor

P B Rothman

R L Miller

Affiliations

Soon will be listed here.

Abstract

Background: Asthma is the most common medical condition during pregnancy. While increased production of T helper cytokines has been reported to occur in both asthma and pregnancy, the effect of T-helper type 2 (Th2) polarization on asthma symptoms during pregnancy has not been well-characterized.

Objective: We hypothesized that systemic Th2 cytokine and chemokine polarization occurs among asthmatics to a greater extent during their pregnancy, and is associated with more severe asthma and increased Th2 polarization in the newborn.

Methods: Fifty-six pregnant asthmatics were recruited from prenatal clinics affiliated with New York Presbyterian Hospital. Systemic production of interleukin-4, interferon-gamma, eotaxin and IP10 were measured by intracytoplasmic staining or ELISA at recruitment, peripartum and post-partum, and in the cord blood. The frequency of asthma symptoms was measured by questionnaires and compared with Th biomarkers.

Results: The chemokine ratio (IP10/eotaxin) declined over the course of pregnancy (from 3.3 +/- 1.3 to 1.4 +/- 0.2, P = 0.016), but IP10 and eotaxin increased post-partum. The decrease in the chemokine ratio was associated with more frequent asthma symptoms. A non-significant trend towards decreased interferon-gamma and increased interleukin-4 production was detected. Cord blood eotaxin levels correlated with maternal levels (r = 0.35, P = 0.03). Other peripartum biomarkers were not associated with Th2 polarization nor with subsequent respiratory symptoms in the newborn.

Conclusion: IP10/eotaxin declined over the course of pregnancy and was associated with worse asthma symptoms. Alterations of Th1/Th2 chemokine balance during pregnancy may identify women prone to more severe asthma during pregnancy.

Citing Articles

Non-allergic factors that influence asthma control in pregnancy.

Rey A, Chelminska M, Damps-Konstanska I Eur J Midwifery. 2024; 8.

PMID: 39206325 PMC: 11350979. DOI: 10.18332/ejm/191295.

Maternal exposure to farming environment protects offspring against allergic diseases by modulating the neonatal TLR-Tregs-Th axis.

Yu J, Liu X, Li Y, Meng S, Wu F, Yan B Clin Transl Allergy. 2018; 8:34.

PMID: 30140427 PMC: 6098605. DOI: 10.1186/s13601-018-0220-0.

IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after antituberculosis treatment.

Yang Q, Cai Y, Zhao W, Wu F, Zhang M, Luo K Clin Vaccine Immunol. 2014; 21(12):1635-44.

PMID: 25274803 PMC: 4248780. DOI: 10.1128/CVI.00499-14.

Incidence and risk factors for exacerbations of asthma during pregnancy.

Ali Z, Ulrik C J Asthma Allergy. 2013; 6:53-60.

PMID: 23671393 PMC: 3650884. DOI: 10.2147/JAA.S43183.

Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers.

Hong C, Yao S, McCann S, Dolnick R, Wallace P, Gong Z Breast Cancer Res Treat. 2013; 139(2):477-88.

PMID: 23624818 PMC: 3912696. DOI: 10.1007/s10549-013-2549-3.

References

Leung T, Wong C, Chan I, Ip W, Lam C, Wong G . Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma. J Allergy Clin Immunol. 2002; 110(3):404-9. DOI: 10.1067/mai.2002.126378. View

Haggerty C, Ness R, Kelsey S, Waterer G . The impact of estrogen and progesterone on asthma. Ann Allergy Asthma Immunol. 2003; 90(3):284-91; quiz 291-3, 347. DOI: 10.1016/S1081-1206(10)61794-2. View

Kay A . Immunomodulation in asthma: mechanisms and possible pitfalls. Curr Opin Pharmacol. 2003; 3(3):220-6. DOI: 10.1016/s1471-4892(03)00038-9. View

Holtzman M . Drug development for asthma. Am J Respir Cell Mol Biol. 2003; 29(2):163-71. DOI: 10.1165/rcmb.F276. View

Schatz M, Dombrowski M, Wise R, Thom E, Landon M, Mabie W . Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol. 2003; 112(2):283-8. DOI: 10.1067/mai.2003.1516. View

Hellings P, Vandekerckhove P, Claeys R, Billen J, Kasran A, Ceuppens J . Progesterone increases airway eosinophilia and hyper-responsiveness in a murine model of allergic asthma. Clin Exp Allergy. 2003; 33(10):1457-63. DOI: 10.1046/j.1365-2222.2003.01743.x. View

Bracken M, Triche E, Belanger K, Saftlas A, Beckett W, Leaderer B . Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol. 2003; 102(4):739-52. DOI: 10.1016/s0029-7844(03)00621-5. View

Macaubas C, de Klerk N, Holt B, Wee C, Kendall G, Firth M . Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. Lancet. 2003; 362(9391):1192-7. DOI: 10.1016/s0140-6736(03)14542-4. View

Prescott S . New concepts of cytokines in asthma: is the Th2/Th1 paradigm out the window?. J Paediatr Child Health. 2003; 39(8):575-9. DOI: 10.1046/j.1440-1754.2003.00237.x. View

10.

Xu B, Pekkanen J, Husman T, Keski-Nisula L, Koskela P . Maternal sex hormones in early pregnancy and asthma among offspring: a case-control study. J Allergy Clin Immunol. 2003; 112(6):1101-4. DOI: 10.1016/j.jaci.2003.09.027. View

11.

Leung T, Wong G, Ko F, Lam C, Fok T . Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis. Thorax. 2005; 60(10):822-6. PMC: 1747220. DOI: 10.1136/thx.2004.039321. View

12.

Dombrowski M, Schatz M, Wise R, Momirova V, Landon M, Mabie W . Asthma during pregnancy. Obstet Gynecol. 2004; 103(1):5-12. DOI: 10.1097/01.AOG.0000103994.75162.16. View

13.

Hijnen D, de Bruin-Weller M, Oosting B, Lebre C, de Jong E, Bruijnzeel-Koomen C . Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol. 2004; 113(2):334-40. DOI: 10.1016/j.jaci.2003.12.007. View

14.

Barr R, Wentowski C, Grodstein F, Somers S, Stampfer M, Schwartz J . Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med. 2004; 164(4):379-86. DOI: 10.1001/archinte.164.4.379. View

15.

Salem M . Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy. 2004; 3(1):97-104. DOI: 10.2174/1568010043483944. View

16.

Kwon H, Belanger K, Bracken M . Effect of pregnancy and stage of pregnancy on asthma severity: a systematic review. Am J Obstet Gynecol. 2004; 190(5):1201-10. DOI: 10.1016/j.ajog.2003.09.057. View

17.

Tateno H, Nakamura H, Minematsu N, Nakajima T, Takahashi S, Nakamura M . Plasma eotaxin level and severity of asthma treated with corticosteroid. Respir Med. 2004; 98(8):782-90. DOI: 10.1016/j.rmed.2004.01.005. View

18.

Schatz M, Harden K, Forsythe A, Chilingar L, Hoffman C, Sperling W . The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol. 1988; 81(3):509-17. View

19.

Wegmann T, Lin H, Guilbert L, Mosmann T . Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol Today. 1993; 14(7):353-6. DOI: 10.1016/0167-5699(93)90235-D. View

20.

Piccinni M, Romagnani S . Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines. Immunol Res. 1996; 15(2):141-50. DOI: 10.1007/BF02918503. View